Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity

Journal: Cell Stem Cell

Published: 2018-06-28

DOI: 10.1016/j.stem.2018.06.002

Affiliations: 5

Authors: 4

Go to article
Institutions FC
Sanford Consortium for Regenerative Medicine, United States of America (USA) 0.50
Department of Medicine, UMN, United States of America (USA) 0.25
Department of Pediatrics, UMN, United States of America (USA) 0.08
Masonic Cancer Center, UMN, United States of America (USA) 0.08
Center for Genome Engineering (CGE), UMTC, United States of America (USA) 0.08

Return